With New Zealanders able to request access to medicinal cannabis dried flower for the first time ever as of today, one of Australia’s leading private medicinal cannabis companies has received export approval from our Kiwi neighbours.
Byron Bay-based Australian Natural Therapeutics Group (ANTG) has been granted the green light to ship its locally cultivated product to New Zealand – the first Aussie company to do so – in partnership with a local distributor of the medicine.
ANTG’s Eve CBD flower will be accessed through NZ’s largest medicinal cannabis distributor NUBU Pharmaceuticals in what the Australian company’s CEO Matthew Cantelo said was a landmark deal for both countries.
“This agreement is not only a historic first for New Zealand, but also beneficial for the Australian industry as a whole,” Cantelo said.
“The high benchmarks in Australia for growing and producing medicinal cannabis has set us up as the best in the world. We have a reputation and climate for growing excellent produce in general – it makes sense that we would produce the highest quality medicinal cannabis product as well.
“Our Kiwi neighbours will also have access to the highest quality Australian flower while their home-grown cultivation industry starts producing.”
NUBU Pharmaceuticals co-founder and CEO Mark Dye said he couldn’t be happier about the deal, which will give New Zealanders access to ANTG’s high quality medicinal cannabis products.
“Being the first company to legally sell cannabis in New Zealand is beyond exciting – I can’t even begin to explain the blood, sweat and tears it has taken to get here,” Dye said.
“I am excited for the patients – they have been calling out for this for decades. I am so proud it is the team at NUBU that has been able to make this happen for them.
“ANTG are very much leading the Australasian cannabis industry. We are over the moon to have them as a distribution partner.”
